2014 annual financial data
Viking Therapeutics 2014 Net income growth
Direct answer
Net income growth was -14,863.85%.
Operating income was -23,467,983 USD and net income was -21,884,183 USD.
Operating cash flow was -1,591,423 USD.
Get free Viking Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -23,467,983 USD
- Net income
- -21,884,183 USD
- Operating cash flow
- -1,591,423 USD